Immunovia AB Share

Immunovia AB is a Swedish diagnostics company focused on the early detection of cancer. The company develops and commercializes blood-based tests designed to improve survival rates and quality of life for cancer patients. Immunovia's primary focus is on pancreatic cancer, a disease known for its aggressive nature and difficulty in early diagnosis. Their innovative testing platform aims to identify individuals at high risk or in the early stages of the disease, enabling earlier intervention and treatment. By leveraging advanced biomarker technology and proprietary algorithms, Immunovia strives to provide clinicians with valuable tools for proactive cancer management. The company operates within the healthcare sector, specifically in the areas of diagnostics, oncology, and personalized medicine, contributing to advancements in cancer detection and patient care.